SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000947871-21-001222
Filing Date
2021-11-18
Accepted
2021-11-18 17:10:22
Documents
2
Group Members
ORBIMED CAPITAL GP VII LLCORBIMED GENESIS GP LLC

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 ss628100_sc13da.htm SC 13D/A 99316
2 JOINT FILING AGREEMENT ss628100_ex9901.htm EX-99.1 5702
  Complete submission text file 0000947871-21-001222.txt   106552
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

IRS No.: 133976876 | State of Incorp.: DE
Type: SC 13D/A

Mailing Address 245 MAIN STREET CAMBRIDGE MA 02142
Business Address 245 MAIN STREET CAMBRIDGE MA 02142 (857) 400-9491
Theseus Pharmaceuticals, Inc. (Subject) CIK: 0001745020 (see all company filings)

IRS No.: 830712806 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-92944 | Film No.: 211425294
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences